Market Tracker

05/04 3:18pm ET

Enzon Pharmaceuticals Inc (NASDAQ:ENZN)

0.48
Delayed Data
As of 3:03pm ET
 -0.005 / -1.03%
Today’s Change
0.39
Today|||52-Week Range
0.90
-29.67%
Year-to-Date
No recent news for Enzon Pharmaceuticals Inc.

Today’s Trading

Previous close0.49
Today’s open0.50
Day’s range0.48 - 0.50
Volume101,719
Average volume (3 months)222,627
Market cap$21.3M
Dividend yield--
Data as of 3:03pm ET, 05/04/2016

Growth & Valuation

Earnings growth (last year)-24.62%
Earnings growth (this year)--
Earnings growth (next 5 years)+53.00%
Revenue growth (last year)-44.00%
P/E ratio1.0
Price/Sales1.73
Price/Book1.18

Competitors

 Today’s
change
Today’s
% change
WINTWindtree Therapeutic...-0.02-0.87%
PRPHProPhase Labs Inc-0.01-0.62%
SPHSSophiris Bio Inc-0.08-5.67%
VKTXViking Therapeutics ...-0.06-4.48%
Data as of 3:02pm ET, 05/04/2016

Financials

Last reporting date--
EPS forecast (this quarter)--
Annual revenue (last year)$17.5M
Annual profit (last year)$21.6M
Net profit margin123.95%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Secretary
Andrew D. Rackear
Principal Financial &
Accounting Officer
Richard L. Feinstein
Corporate headquarters
Cranford, New Jersey

Forecasts